Aclaris Therapeutics, Inc.【ACRS】 業績推移・財務諸表

機能の使い方
(単位:千ドル) 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25
売上高 - - - - - - - 684 999 1,118 3,676 1,628 3,669 5,041 5,865 983 1,095 1,407 2,046 1,449 1,580 1,777 1,824 1,659 1,501 1,453 1,528 19,018 7,753 2,528 1,869 9,282 17,570 2,398 2,766 4,346 9,211 1,455 1,777
売上成長率(%) - - - - - - - - - - - 48.0 -53.2 -47.6 -39.3 -35.8
売上原価 - - - - - - - 453 754 967 1,181 1,193 3,509 2,777 2,703 826 - 1,269 1,389 1,189 1,286 1,202 1,263 1,099 1,149 1,155 1,068 923 877 808 1,042 848 725 809 624 654 705 506 515
売上総利益 - - - - - - - 231 245 151 2,495 435 160 - - - - - - - - - - - - - - - - - - - - - - - - - -
売上総利益率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
研究開発費 - 9,535 9,836 7,162 6,943 7,772 7,965 10,864 13,189 13,606 13,984 15,931 19,537 19,919 17,622 16,183 11,565 9,444 6,466 6,866 8,956 7,838 7,897 13,976 14,102 14,306 18,779 23,656 21,072 22,587 25,275 23,876 26,646 9,845 8,759 5,956 9,026 11,584 11,449
営業費用 4,802 13,139 12,989 10,812 11,627 12,930 15,295 18,987 25,687 31,099 34,473 33,885 39,198 42,376 55,656 23,847 18,648 16,913 - - - 30,306 19,830 21,954 24,394 20,360 22,522 39,892 36,832 32,446 33,684 40,859 21,617 21,329 15,620 14,817 108,886 19,539 20,185
営業利益 - -13,139 -12,989 -10,812 -11,627 -12,930 -15,295 -18,756 -25,442 -30,948 -31,978 -33,450 -39,038 -37,335 -49,791 -22,864 -17,553 -15,506 -11,381 -10,465 -13,560 -28,529 -18,006 -20,295 -22,893 -18,907 -20,994 -20,874 -29,079 -29,918 -31,815 -31,577 -4,047 -18,931 -12,854 -10,471 -99,675 -18,084 -18,408
営業利益率 (%) - - - - - - - -464.7 -240.9 -1082.1 -1242.9 -1035.9
純利益 -4,714 -13,039 -12,871 -10,694 -11,475 -12,559 -14,838 -18,192 -22,934 -30,229 -31,218 -32,740 -38,551 -37,565 -49,876 -55,319 -18,594 -15,586 -11,597 -10,659 -13,173 -28,754 -18,161 -21,146 -22,804 -18,789 -20,532 -19,952 -27,635 -28,160 -29,569 -29,261 -1,491 -16,941 -10,986 -7,586 -96,552 -15,085 -15,429
純利益率(%) - - - - - - - -397.2 -174.6 -1048.2 -1036.8 -868.3
一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - -0.31 -0.31 -0.3 -0.41 -0.42 -0.42 -0.41 -0.02 -0.24 -0.15 -0.11 -1.21 -0.12 -0.13
希薄化後一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - -0.31 -0.31 -0.3 -0.41 -0.42 -0.42 -0.41 -0.02 -0.24 -0.15 -0.11 -1.21 -0.12 -0.13
EBITDA - - - - - - - - -12,612 -10,292 -99,532 -17,956 -18,294
EBITDAマージン(%) - - - - - - - - -456.0 -236.8 -1080.6 -1234.1 -1029.5